Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 1990; Volume 38,Issue 6
  • You have access
    Glycine site-directed agonists reverse the actions of ethanol at the N-methyl-D-aspartate receptor.
    C S Rabe and B Tabakoff
    Molecular Pharmacology December 1990, 38 (6) 753-757;
  • You have access
    High affinity forskolin inhibition of L-type Ca2+ current in cardiac cells.
    M Boutjdir, P F Méry, R Hanf, A Shrier and R Fischmeister
    Molecular Pharmacology December 1990, 38 (6) 758-765;
  • You have access
    Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase.
    R Fernandez-Larsson and J L Patterson
    Molecular Pharmacology December 1990, 38 (6) 766-770;
  • You have access
    Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
    T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
    Molecular Pharmacology December 1990, 38 (6) 771-778;
  • You have access
    Homomeric GluR1 excitatory amino acid receptors expressed in Xenopus oocytes.
    T L Dawson, R A Nicholas and R Dingledine
    Molecular Pharmacology December 1990, 38 (6) 779-784;
  • You have access
    Bradykinin-induced modulation of calcium signals in rat dorsal root ganglion neurons in vitro.
    D Bleakman, S A Thayer, S R Glaum and R J Miller
    Molecular Pharmacology December 1990, 38 (6) 785-796;
  • You have access
    3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
    D A Weidner and J P Sommadossi
    Molecular Pharmacology December 1990, 38 (6) 797-804;
  • You have access
    Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    S Lazareno, N J Buckley and F F Roberts
    Molecular Pharmacology December 1990, 38 (6) 805-815;
  • You have access
    Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
    J L Bueb, M Mousli, C Bronner, B Rouot and Y Landry
    Molecular Pharmacology December 1990, 38 (6) 816-822;
  • You have access
    Phosphorylation-independent effects of second messenger system modulators on gamma-aminobutyric acidA receptor complex function.
    N J Leidenheimer, M D Browning, T V Dunwiddie, L D Hahner and R A Harris
    Molecular Pharmacology December 1990, 38 (6) 823-828;
  • You have access
    Effects of hepatic ischemia-reperfusion injury on the hepatic mixed function oxidase system in rats.
    T D Lindstrom, B R Hanssen and A M Bendele
    Molecular Pharmacology December 1990, 38 (6) 829-835;
  • You have access
    Regulation of guinea pig ileal electrolyte transport by M3-muscarinic acetylcholine receptors in vitro.
    J F Kachur, B L Sturm, T S Gaginella and L Noronha-Blob
    Molecular Pharmacology December 1990, 38 (6) 836-840;
  • You have access
    Solubilization and partial characterization of inositol 1,4,5-trisphosphate receptor of bovine adrenal cortex reveal similarities with the receptor of rat cerebellum.
    G Guillemette, I Favreau, G Boulay and M Potier
    Molecular Pharmacology December 1990, 38 (6) 841-847;
  • You have access
    Tissue levels, source, and regulation of 3'-AMP: an intracellular inhibitor of adenylyl cyclases.
    M Bushfield, I Shoshani and R A Johnson
    Molecular Pharmacology December 1990, 38 (6) 848-853;
  • You have access
    Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
    P H Reggio, H H Seltzman, D R Compton, W R Prescott and B R Martin
    Molecular Pharmacology December 1990, 38 (6) 854-862;
  • You have access
    Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
    E L Ochoa, L A Li, A Plummer and M G McNamee
    Molecular Pharmacology December 1990, 38 (6) 863-871;
  • You have access
    Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis.
    J Wess, T I Bonner and M R Brann
    Molecular Pharmacology December 1990, 38 (6) 872-877;
  • You have access
    Up-regulation of angiotensin II receptors by in vitro differentiation of murine N1E-115 neuroblastoma cells.
    L P Reagan, X H Ye, R Mir, L R DePalo and S J Fluharty
    Molecular Pharmacology December 1990, 38 (6) 878-886;
  • You have access
    Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
    R J Lukas, T Audhya, G Goldstein and L Lucero
    Molecular Pharmacology December 1990, 38 (6) 887-894;
  • You have access
    Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
    J R Hu and E E el-Fakahany
    Molecular Pharmacology December 1990, 38 (6) 895-903;
  • You have access
    Mechanism of the cardiotoxic action of palytoxin.
    C Frelin, P Vigne and J P Breittmayer
    Molecular Pharmacology December 1990, 38 (6) 904-909;
  • You have access
    Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
    F Orosz, M Telegdi, K Liliom, M Solti, D Korbonits and J Ovádi
    Molecular Pharmacology December 1990, 38 (6) 910-916;
  • You have access
    Mode of action of alpha-latrotoxin: role of divalent cations in Ca2(+)-dependent and Ca2(+)-independent effects mediated by the toxin.
    L Rosenthal, D Zacchetti, L Madeddu and J Meldolesi
    Molecular Pharmacology December 1990, 38 (6) 917-923;
  • You have access
    Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
    H I Mosberg, D L Heyl, R C Haaseth, J R Omnaas, F Medzihradsky and C B Smith
    Molecular Pharmacology December 1990, 38 (6) 924-928;
  • You have access
    Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
    Z Zhu, R F Schinazi, C K Chu, G J Williams, C B Colby and J P Sommadossi
    Molecular Pharmacology December 1990, 38 (6) 929-938;
  • You have access
    Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
    R F Bruns and J H Fergus
    Molecular Pharmacology December 1990, 38 (6) 939-949;
  • You have access
    Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.
    R F Bruns, J H Fergus, L L Coughenour, G G Courtland, T A Pugsley, J H Dodd and F J Tinney
    Molecular Pharmacology December 1990, 38 (6) 950-958;
  • You have access
    Ethanol potentiates oxygen uptake and toxicity due to menadione bisulfite in perfused rat liver.
    P E Ganey, Y Takei, F C Kauffman and R G Thurman
    Molecular Pharmacology December 1990, 38 (6) 959-964;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 38, Issue 6
1 Dec 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics